{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:00:02Z","timestamp":1791442802949,"version":"4.3.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13643-017-0483-x","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T04:49:42Z","timestamp":1492663782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data"],"prefix":"10.1186","volume":"6","author":[{"given":"Tatiana","family":"Raskovalova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Deegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pavlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Stirnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-6586","authenticated-orcid":false,"given":"Jos\u00e9","family":"Labar\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"483_CR1","first-page":"1121","volume-title":"Williams Hematology","author":"A Zimran","year":"2016","unstructured":"Zimran A, Elstein D. Chapter 72: Gaucher disease and related lysosomal storage diseases. In: Kaushansky K, Lichtman MA, Prchal JT, Levi M, Press OW, Burns LJ, et al., editors. Williams Hematology. 9th ed. New York: McGraw-Hill Education; 2016. p. 1121\u201331.","edition":"9"},{"key":"483_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/asheducation.V2012.1.13.3797921","volume":"2012","author":"GA Grabowski","year":"2012","unstructured":"Grabowski GA. Gaucher disease and other storage disorders. Hematology Am Soc Hematol Educ Program. 2012;2012:13\u20138.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"Suppl 1","key":"483_CR3","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1002\/ajh.24063","volume":"90","author":"GA Grabowski","year":"2015","unstructured":"Grabowski GA, Zimran A, Ida H. Gaucher disease types 1 and 3: phenotypic characterization of large populations from the ICGG Gaucher Registry. Am J Hematol. 2015;90 Suppl 1:S12\u20138.","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"483_CR4","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1002\/ajh.24055","volume":"90","author":"PK Mistry","year":"2015","unstructured":"Mistry PK, Belmatoug N, Vom Dahl S, Giugliani R. Understanding the natural history of Gaucher disease. Am J Hematol. 2015;90 Suppl 1:S6\u2013S11.","journal-title":"Am J Hematol"},{"key":"483_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","volume":"372","author":"GA Grabowski","year":"2008","unstructured":"Grabowski GA. Phenotype, diagnosis, and treatment of Gaucher\u2019s disease. Lancet. 2008;372:1263\u201371.","journal-title":"Lancet"},{"key":"483_CR6","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","volume":"324","author":"NW Barton","year":"1991","unstructured":"Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, et al. Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease. N Engl J Med. 1991;324:1464\u201370.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"483_CR7","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1002\/ajh.24056","volume":"90","author":"J Charrow","year":"2015","unstructured":"Charrow J, Scott CR. Long-term treatment outcomes in Gaucher disease. Am J Hematol. 2015;90 Suppl 1:S19\u201324.","journal-title":"Am J Hematol"},{"key":"483_CR8","first-page":"CD010324","volume":"3","author":"E Shemesh","year":"2015","unstructured":"Shemesh E, Deroma L, Bembi B, Deegan P, Hollak C, Weinreb NJ, et al. Enzyme replacement and substrate reduction therapy for Gaucher disease. Cochrane Database Syst Rev. 2015;3:CD010324.","journal-title":"Cochrane Database Syst Rev"},{"key":"483_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.07.010","volume":"41","author":"NJ Weinreb","year":"2004","unstructured":"Weinreb NJ, Aggio MC, Andersson HC, Andria G, Charrow J, Clarke JT, et al. Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients. Semin Hematol. 2004;41:15\u201322.","journal-title":"Semin Hematol"},{"key":"483_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","volume":"34","author":"JM Aerts","year":"2011","unstructured":"Aerts JM, Kallemeijn WW, Wegdam W, Joao Ferraz M, van Breemen MJ, Dekker N, et al. Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies. J Inherit Metab Dis. 2011;34:605\u201319.","journal-title":"J Inherit Metab Dis"},{"key":"483_CR11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1172\/JCI117084","volume":"93","author":"CE Hollak","year":"1994","unstructured":"Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest. 1994;93:1288\u201392.","journal-title":"J Clin Invest"},{"key":"483_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10545-014-9711-x","volume":"37","author":"L Dussen van","year":"2014","unstructured":"van Dussen L, Hendriks EJ, Groener JE, Boot RG, Hollak CE, Aerts JM. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy. J Inherit Metab Dis. 2014;37:991\u20131001.","journal-title":"J Inherit Metab Dis"},{"key":"483_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13023-016-0413-3","volume":"11","author":"BE Smid","year":"2016","unstructured":"Smid BE, Ferraz MJ, Verhoek M, Mirzaian M, Wisse P, Overkleeft HS, et al. Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients. Orphanet J Rare Dis. 2016;11:28.","journal-title":"Orphanet J Rare Dis"},{"key":"483_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cca.2007.02.042","volume":"381","author":"A Schoonhoven","year":"2007","unstructured":"Schoonhoven A, Rudensky B, Elstein D, Zimran A, Hollak CE, Groener JE, et al. Monitoring of Gaucher patients with a novel chitotriosidase assay. Clin Chim Acta. 2007;381:136\u20139.","journal-title":"Clin Chim Acta"},{"key":"483_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bcmd.2005.05.005","volume":"35","author":"PB Deegan","year":"2005","unstructured":"Deegan PB, Moran MT, McFarlane I, Schofield JP, Boot RG, Aerts JM, et al. Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells Mol Dis. 2005;35:259\u201367.","journal-title":"Blood Cells Mol Dis"},{"key":"483_CR16","doi-asserted-by":"publisher","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","volume":"273","author":"RG Boot","year":"1998","unstructured":"Boot RG, Renkema GH, Verhoek M, Strijland A, Bliek J, de Meulemeester TM, et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem. 1998;273:25680\u20135.","journal-title":"J Biol Chem"},{"key":"483_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","volume":"103","author":"RG Boot","year":"2004","unstructured":"Boot RG, Verhoek M, de Fost M, Hollak CE, Maas M, Bleijlevens B, et al. Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood. 2004;103:33\u20139.","journal-title":"Blood"},{"key":"483_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/MD.0b013e3182057be4","volume":"90","author":"PB Deegan","year":"2011","unstructured":"Deegan PB, Pavlova E, Tindall J, Stein PE, Bearcroft P, Mehta A, et al. Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Medicine (Baltimore). 2011;90:52\u201360.","journal-title":"Medicine (Baltimore)"},{"key":"483_CR19","doi-asserted-by":"publisher","first-page":"c221","DOI":"10.1136\/bmj.c221","volume":"340","author":"RD Riley","year":"2010","unstructured":"Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.","journal-title":"BMJ"},{"key":"483_CR20","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/sim.4780141902","volume":"14","author":"LA Stewart","year":"1995","unstructured":"Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med. 1995;14:2057\u201379.","journal-title":"Stat Med"},{"key":"483_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"483_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","volume":"98","author":"KG Moons","year":"2012","unstructured":"Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98:683\u201390.","journal-title":"Heart"},{"key":"483_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ajh.23381","volume":"88","author":"DE Gonzalez","year":"2013","unstructured":"Gonzalez DE, Turkia HB, Lukina EA, Kisinovsky I, Dridi MF, Elstein D, et al. Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: results from a randomized, double-blind, multinational, Phase 3 study. Am J Hematol. 2013;88:166\u201371.","journal-title":"Am J Hematol"},{"key":"483_CR24","doi-asserted-by":"publisher","first-page":"40911","DOI":"10.1074\/jbc.M301804200","volume":"278","author":"B Aguilera","year":"2003","unstructured":"Aguilera B, Ghauharali-van der Vlugt K, Helmond MT, Out JM, Donker-Koopman WE, Groener JE, et al. Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase. J Biol Chem. 2003;278:40911\u20136.","journal-title":"J Biol Chem"},{"issue":"Suppl 2","key":"483_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1023\/A:1012492429191","volume":"24","author":"CE Hollak","year":"2001","unstructured":"Hollak CE, Maas M, Aerts JM. Clinically relevant therapeutic endpoints in type I Gaucher disease. J Inherit Metab Dis. 2001;24 Suppl 2:97\u2013105. discussion 87-8.","journal-title":"J Inherit Metab Dis"},{"key":"483_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40\u20136.","journal-title":"J Clin Epidemiol"},{"key":"483_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2105\/AJPH.2011.300343","volume":"102","author":"LE Griffith","year":"2012","unstructured":"Griffith LE, Shannon HS, Wells RP, Walter SD, Cole DC, Cote P, et al. Individual participant data meta-analysis of mechanical workplace risk factors and low back pain. Am J Public Health. 2012;102:309\u201318.","journal-title":"Am J Public Health"},{"key":"483_CR28","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2141.2012.09175.x","volume":"158","author":"CE Hollak","year":"2012","unstructured":"Hollak CE, Belmatoug N, Cole JA, Vom Dahl S, Deegan PB, Goldblatt J, et al. Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years. Br J Haematol. 2012;158:528\u201338.","journal-title":"Br J Haematol"},{"key":"483_CR29","volume-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System","author":"WHO","year":"2011","unstructured":"WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization; 2011."},{"key":"483_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u201336.","journal-title":"Ann Intern Med"},{"key":"483_CR31","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","volume":"313","author":"LA Stewart","year":"2015","unstructured":"Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, et al. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313:1657\u201365.","journal-title":"JAMA"},{"key":"483_CR32","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1136\/bmj.312.7039.1153","volume":"312","author":"JM Bland","year":"1996","unstructured":"Bland JM, Altman DG. The use of transformation when comparing two means. BMJ. 1996;312:1153.","journal-title":"BMJ"},{"key":"483_CR33","volume":"7","author":"GB Stewart","year":"2012","unstructured":"Stewart GB, Altman DG, Askie LM, Duley L, Simmonds MC, Stewart LA. Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice. PLoS One. 2012;7, e46042.","journal-title":"PLoS One"},{"key":"483_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386","volume-title":"Introduction to meta-analysis","author":"M Borenstein","year":"2009","unstructured":"Borenstein M, Hedges L, Higgins JP, Rothstein H. Introduction to meta-analysis. Chichester: Wiley; 2009."},{"key":"483_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/0272989X9201200405","volume":"12","author":"DK McClish","year":"1992","unstructured":"McClish DK. Combining and comparing area estimates across studies or strata. Med Decis Making. 1992;12:274\u20139.","journal-title":"Med Decis Making"},{"key":"483_CR36","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/sim.918","volume":"20","author":"JP Higgins","year":"2001","unstructured":"Higgins JP, Whitehead A, Turner RM, Omar RZ, Thompson SG. Meta-analysis of continuous outcome data from individual patients. Stat Med. 2001;20:2219\u201341.","journal-title":"Stat Med"},{"key":"483_CR37","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1002\/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L","volume":"19","author":"RM Turner","year":"2000","unstructured":"Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med. 2000;19:3417\u201332.","journal-title":"Stat Med"},{"key":"483_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536867X0900900101","volume":"9","author":"M Pepe","year":"2009","unstructured":"Pepe M, Longton G, Janes H. Estimation and comparison of receiver operating characteristic curves. Stata J. 2009;9:1.","journal-title":"Stata J"},{"key":"483_CR39","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"483_CR40","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.","journal-title":"BMJ"},{"key":"483_CR41","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","volume":"336","author":"HJ Schunemann","year":"2008","unstructured":"Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106\u201310.","journal-title":"BMJ"},{"key":"483_CR42","doi-asserted-by":"publisher","first-page":"889","DOI":"10.7326\/0003-4819-149-12-200812160-00008","volume":"149","author":"MM Leeflang","year":"2008","unstructured":"Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008;149:889\u201397.","journal-title":"Ann Intern Med"},{"key":"483_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12916-015-0376-6","volume":"13","author":"B Villain","year":"2015","unstructured":"Villain B, Dechartres A, Boyer P, Ravaud P. Feasibility of individual patient data meta-analyses in orthopaedic surgery. BMC Med. 2015;13:131.","journal-title":"BMC Med"},{"key":"483_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1164","volume":"7","author":"AA Veroniki","year":"2016","unstructured":"Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7:55\u201379.","journal-title":"Res Synth Methods"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-017-0483-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T22:29:24Z","timestamp":1601936964000},"score":1,"resource":{"primary":{"URL":"http:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-017-0483-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1186\/s13643-017-0483-x","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]},"article-number":"87"}}